Gardner Lewis Asset Management’s Gilead Sciences GILD Stock Holding History

Gardner Lewis Asset Management’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-59,322	Closed	-$5.59M	–	96
2014 Q4	$5.59M	Buy	59,322 +8,958	+18%	+$926K	1.13%	32
2014 Q3	$5.36M	Sell	50,364 -7,190	-12%	-$704K	1.07%	37
2014 Q2	$4.77M	Sell	57,554 -16,401	-22%	-$1.28M	1.32%	29
2014 Q1	$5.24M	Sell	73,955 -8,800	-11%	-$690K	1.66%	20
2013 Q4	$6.21M	Sell	82,755 -3,865	-4%	-$269K	2.09%	14
2013 Q3	$5.45M	Sell	86,620 -3,595	-4%	-$215K	1.48%	24
2013 Q2	$4.63M	Buy	+90,215	New	+$4.7M	1.2%	32

Other funds holding GILD

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return

Gardner Lewis Asset Management's GILD Position: Q1 2015 in Review

Gardner Lewis Asset Management sold out of Gilead Sciences (GILD) in Q1 2015, closing a stake of 59,322 shares — an estimated $5.59M sold.

Gardner Lewis Asset Management first reported a position in GILD in Q2 2013 and held it in 7 quarters. The position peaked at $6.21M in Q4 2013. 1,492 funds tracked by Wall St. Rank hold GILD as of Q1 2015.

Gardner Lewis Asset Management reported no remaining Gilead Sciences position as of Q1 2015 after selling out during the quarter.
Gardner Lewis Asset Management sold 59,322 Gilead Sciences shares in Q1 2015, an estimated $5.59M.
Gardner Lewis Asset Management first reported a position in Gilead Sciences in Q2 2013 and held it in 7 quarters.
Gardner Lewis Asset Management's Gilead Sciences position peaked at $6.21M in Q4 2013.
1,492 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2015.

Based on Gardner Lewis Asset Management's 13F filing for Q1 2015, filed 14 May 2015.